Molecular Devices products to be supplied and serviced by Bio-Strategy
After 1 June, Molecular Devices products (previously supplied by MDS Analytical Technologies) will be supplied, serviced and supported by Bio-Strategy in both Australia and New Zealand.
Most of MDS Analytical Technologies' Australian employees have joined Bio-Strategy, and instrument warranties and ongoing service agreements have also been transferred to Bio-Strategy.
For any concerns or questions regarding this transition, Bio-Strategy can be contacted on:
Free phone: 1800 00 84 53
Email: info@bio-strategy.com
Web: www.bio-strategy.com
Billion-dollar deal for UQ's molecular clamp vaccine tech
Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...
Director of scandal-ridden Forensic Science Queensland resigns
Dr Linzi Wilson-Wilde resigned from her position one month after being suspended by Queensland...
$492m pathology hub coming to Westmead Health Precinct
The NSW Health Pathology Statewide Hub will be delivered to Westmead Health Precinct, as part of...
